MetrionAIIntelligence

Sign in Register

Home Watchlist Market News High Impact News Market Movers Screener Portfolio Calculators Heatmap Compare Calendars Crypto Forex Macro Maps

Research Tools

Financial Analysis Analyst Estimates Insider Trading Market Guide Trading Ideas Charts

Financial Analysis

Highlights Income Statement Balance Sheet Cash Flow Multiples Profitability

Loading market dashboard

My Watchlist

Sign in to track securities

Create an account to keep a persistent watchlist.

Home High Impact News Market Movers

Loading stock research

bioAffinity Technologies, Inc.

BIAF

HealthcareNASDAQUS

Sign in to save

$1.73

-$0.15 (-7.98%)

Overview Financials Analysis Valuation Thesis Ownership Compare AI Report News

BIAF

1Y-0.15 (-7.98%)

Candles, volume, SMA 20, and SMA 50

O 1.86H 2.05L 1.72C 1.73Date Jun 5

BIAF

SMA 20 SMA 50 Vol 229.50KEEarnings dates

Open in Chartsfor further analysis

Business Description

Open for the full company profile when you need deeper context.

ShowHide

bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is based in San Antonio, Texas.

Key Metrics

Quick size, liquidity, and volatility measures for the stock.

Market Cap?$7.85M

Volume?229.34K

Avg Volume?8.61M

52w Range$0.693 - $13.80

Beta?-1.33

Price Performance

1M

-18.4%

$2.12 to $1.73

YTD

+46.6%

$1.18 to $1.73

1Y

-79.7%

$8.53 to $1.73

3Y

-96.8%

$54.90 to $1.73

5Y

N/A

history unavailable

10Y

N/A

history unavailable

Company Details

CEO, industry, employees, IPO date, currency, and website.

ShowHide

CEOMaria Zannes

IndustryMedical - Diagnostics & Research

Employees57

IPO Date2022-09-01

CurrencyUSD

Websitewww.bioaffinitytech.com

Related stocks

Check out other names from the same Medical - Diagnostics & Research industry as BIAF.

Artelo Biosciences, Inc.

Carisma Therapeutics, Inc.

GT Biopharma, Inc.

Lipella Pharmaceuticals Inc.

Mobile-health Network Solutions Class A Ordinary Shares

Psyence Biomedical Ltd.

Protagenic Therapeutics, Inc.

Revelation Biosciences, Inc.

Salarius Pharmaceuticals, Inc.

WORK Medical Technology Group Ltd.